Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Las Vegas Sands
LVS
$32.3B
| $18.5M | 0.01% |
395,683
-89,669
| -18% | -$4.28M |
|
727
BellRing Brands
BRBR
$1.53B
| $18.4M | 0.01% |
889,243
-40,747
| -4% | -$802K |
|
|
ZNGA
728
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $18.4M | 0.01% |
2,022,122
+1,608,639
| +389% | +$15M |
|
|
LONA
729
LeonaBio Inc
LONA
$68.5M
| $18.1M | 0.01% |
+100,320
| New | +$16.8M |
|
730
Codexis
CDXS
$159M
| $18M | 0.01% |
1,529,770
+36,814
| +2% | +$459K |
|
731
US Bancorp
USB
$98B
| $17.9M | 0.01% |
499,702
-5,205,022
| -91% | -$190M |
|
732
Corpay
CPAY
$25.5B
| $17.8M | 0.01% |
74,625
-357,881
| -83% | -$88.4M |
|
733
Fortinet
FTNT
$113B
| $17.6M | 0.01% |
746,320
+18,440
| +3% | +$476K |
|
|
CMBT
734
CMB.TECH NV
CMBT
$4.65B
| $17.6M | 0.01% |
1,990,822
| – | – |
|
735
Enterprise Products Partners
EPD
$82.5B
| $17.5M | 0.01% |
1,109,517
-29,709
| -3% | -$520K |
|
|
PE
736
DELISTED
PARSLEY ENERGY INC
PE
| $17.4M | 0.01% |
1,861,845
-320,284
| -15% | -$3.43M |
|
|
SRDX
737
DELISTED
Surmodics
SRDX
| $17.4M | 0.01% |
447,264
+5,017
| +1% | +$220K |
|
738
Canadian National Railway
CNI
$76.9B
| $17.4M | 0.01% |
163,751
+11,453
| +8% | +$1.15M |
|
739
Paycom
PAYC
$7.53B
| $17.3M | 0.01% |
55,590
-23,367
| -30% | -$6.83M |
|
|
DCPH
740
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $17.2M | 0.01% |
335,306
+304
| +0.1% | +$14.9K |
|
741
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $17.1M | 0.01% |
+1,118,261
| New | +$21M |
|
|
MPT
742
Medical Properties Trust
MPT
$2.81B
| $17.1M | 0.01% |
970,893
-385,265
| -28% | -$7.17M |
|
743
Franco-Nevada
FNV
$42.7B
| $16.9M | 0.01% |
121,636
-89,515
| -42% | -$13.3M |
|
|
MRSN
744
DELISTED
Mersana Therapeutics
MRSN
| $16.9M | 0.01% |
36,354
+34,059
| +1,484% | +$17.2M |
|
745
Idexx Laboratories
IDXX
$44.1B
| $16.7M | 0.01% |
42,527
-47,905
| -53% | -$17.7M |
|
|
ONT
746
Onterris Inc
ONT
$731M
| $16.7M | 0.01% |
+700,646
| New | +$17.8M |
|
747
Atmos Energy
ATO
$29.1B
| $16.6M | 0.01% |
174,097
-91,975
| -35% | -$9.18M |
|
|
NVO
748
Novo Nordisk
NVO
$228B
| $16.6M | 0.01% |
479,108
+48,422
| +11% | +$1.61M |
|
749
Factset
FDS
$9.35B
| $16.6M | 0.01% |
49,570
+18,043
| +57% | +$6.24M |
|
750
Melco Resorts & Entertainment
MLCO
$2.24B
| $16.6M | 0.01% |
994,555
-9,851
| -1% | -$175K |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.